A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,931 shares of BNTX stock, worth $465,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,931
Previous 3,349 17.38%
Holding current value
$465,391
Previous $269,000 73.23%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$78.36 - $124.66 $45,605 - $72,552
582 Added 17.38%
3,931 $466,000
Q2 2024

Jul 30, 2024

SELL
$80.36 - $102.87 $5.23 Million - $6.69 Million
-65,079 Reduced 95.11%
3,349 $269,000
Q1 2024

May 01, 2024

BUY
$88.96 - $112.35 $2.81 Million - $3.55 Million
31,615 Added 85.88%
68,428 $6.31 Million
Q4 2023

Jan 24, 2024

SELL
$90.91 - $112.75 $4.03 Million - $4.99 Million
-44,290 Reduced 54.61%
36,813 $3.89 Million
Q3 2023

Oct 26, 2023

BUY
$98.5 - $125.08 $658,177 - $835,784
6,682 Added 8.98%
81,103 $8.81 Million
Q2 2023

Aug 10, 2023

BUY
$102.58 - $129.66 $504,180 - $637,278
4,915 Added 7.07%
74,421 $8.03 Million
Q1 2023

May 04, 2023

BUY
$122.57 - $153.67 $129,188 - $161,968
1,054 Added 1.54%
69,506 $8.66 Million
Q4 2022

Feb 09, 2023

BUY
$118.43 - $186.05 $592,268 - $930,436
5,001 Added 7.88%
68,452 $10.3 Million
Q3 2022

Nov 10, 2022

BUY
$127.65 - $183.11 $842,362 - $1.21 Million
6,599 Added 11.61%
63,451 $8.56 Million
Q2 2022

Jul 26, 2022

BUY
$123.25 - $186.24 $4.48 Million - $6.77 Million
36,372 Added 177.6%
56,852 $8.48 Million
Q1 2022

May 10, 2022

SELL
$126.25 - $231.85 $330,648 - $607,215
-2,619 Reduced 11.34%
20,480 $3.49 Million
Q4 2021

Feb 08, 2022

BUY
$216.64 - $362.52 $4.48 Million - $7.5 Million
20,684 Added 856.48%
23,099 $5.96 Million
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $34,596 - $75,134
168 Added 7.48%
2,415 $659,000
Q2 2021

Aug 11, 2021

BUY
$113.32 - $241.49 $254,630 - $542,628
2,247 New
2,247 $503,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.